On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- What are the unmet needs in TB therapy?
- TB is a global disease
- TB is a multidimensional problem
- Current TB therapies - active TB
- Current TB therapies - latent TB
- Unmet needs in TB therapy
- Desired regimen profiles
- The approaches in TB drug development
- Process for TB drug development
- Conventional approach 1
- Conventional approach 2
- Conventional approach: issues
- New approach
- Process for novel regimen development
- New approach: advantages and challenges
- How to identify novel TB regimens
- Drug classes available for regimen development
- Drug to regimen
- Mouse infection model
- PaMZ - bactericidal activity in mouse model
- PaMZ - sterilizing activity in mouse model
- PaMZ - combination EBA design (NC-001)
- PaMZ - combination EBA results (NC-001)
- Summary
- Thank you!
Topics Covered
- Current therapies against tuberculosis and unmet needs
- Desired profile for new TB drug regimen
- Current approaches in TB drug development
- New approaches in TB regimen development
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Ma, Z. (2013, February 28). Development of new regimens for tuberculosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/JTZF3192.Export Citation (RIS)
Publication History
- Published on February 28, 2013
Financial Disclosures
- Dr. Zhenkun Ma has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.